SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001113148-17-000006
Filing Date
2017-05-09
Accepted
2017-05-09 16:00:04
Documents
56
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q infi-20170331x10q.htm 10-Q 821554
2 EXHIBIT 31.1 ex-311q12017.htm EX-31.1 10539
3 EXHIBIT 31.2 ex-312q12017.htm EX-31.2 11786
4 EXHIBIT 32.1 ex-321q12017.htm EX-32.1 6167
5 EXHIBIT 32.2 ex-322q12017.htm EX-32.2 6208
  Complete submission text file 0001113148-17-000006.txt   3768763

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT infi-20170331.xml EX-101.INS 534947
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20170331.xsd EX-101.SCH 41672
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20170331_cal.xml EX-101.CAL 56287
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20170331_def.xml EX-101.DEF 169885
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20170331_lab.xml EX-101.LAB 479473
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20170331_pre.xml EX-101.PRE 265847
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 17826266
SIC: 2834 Pharmaceutical Preparations